Discordant HER2/Neu Status of Breast Cancer.

Discordant HER2/Neu Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01935739

Enrollment

105

Registered

2013-09-05

Start date

2010-06-30

Completion date

2011-06-30

Last updated

2013-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Neoplasm of Breast.

Brief summary

The purpose of this study is to determine discordant HER2/neu status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.

Detailed description

HER2/neu status of primary breast tumor and axillary lymph nodes were tested by IHC staining. In the cases of equivocal result of IHC, FISH test were performed. The result of HER2/neu status between primary breast tumor and axillary lymph node were analyzed.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

25 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Breast cancer patients stage I,II and III with axillary lymph nodes metastasis.

Exclusion criteria

* Breast cancer patients stage I,II and III without axillary lymph nodes metastasis.

Design outcomes

Primary

Measure	Time frame	Description
Association of HER2/neu status between primary breast tumor and axillary lymph nodes	up to 1 year	Association of HER2/neu status between primary breast tumor and axillary lymph nodes was analyzed by using the χ2 test

Countries

Thailand

Outcome results